DEPDC5 does it all: Shared genetics for diverse epilepsy syndromes

Annals of Neurology

Volumn 75, Issue 5, 2014, Pages 631-633

  Poduri, Annapurna ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

CELL GROWTH; CELL PROLIFERATION; CLINICAL PRACTICE; CORTICAL DYSPLASIA; DEPDC5 GENE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOPHENOTYPE; EPILEPSY; EPILEPTOGENESIS; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GENE; GENE MUTATION; GENETICS; GERMLINE MUTATION; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; SOMATIC MUTATION; TEMPORAL LOBE EPILEPSY;

BRAIN; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MUTATION; REPRESSOR PROTEINS; TOR SERINE-THREONINE KINASES;

EID: 84902167691     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24160     Document Type: Note

References (23)

1. Annegers JF, Hauser WA, Anderson VE, Kurland LT,. The risks of seizure disorders among relatives of patients with childhood onset epilepsy. Neurology 1982; 32: 174-179.
2. Peljto AL, Barker-Cummings C, Vasoli VM, et al. Familial risk of epilepsy: a population-based study. Brain 2014; 137: 795-805.
3. Epi4K Consortium. Gene discovery in 4,000 genomes. Epilepsia 2012; 53: 1457-1467.
4. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11: 201-203.
5. Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 2013; 45: 552-555.
6. Heron SE, Smith KR, Bahlo M, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012; 44: 1188-1190.
7. Sansoni V, Forcella M, Mozzi A, et al. Functional characterization of a CRH missense mutation identified in an ADNFLE family. PLoS One 2013; 8: e61306.
8. De Fusco M, Becchetti A, Patrignani A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000; 26: 275-276.
9. Scheffer IE, Jones L, Pozzebon M, et al. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann Neurol 1995; 38: 633-642.
10. Dimassi S, Labalme A, Lesca G, et al. A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2. Epilepsia 2014; 55: 370-378.
11. Lal D, Reinthaler EM, Altmüller J, et al. RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PLoS One 2013; 8: e73323.
12. Lemke JR, Lal D, Reinthaler EM, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013; 45: 1067-1072.
13. Lesca G, Rudolf G, Bruneau N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013; 45: 1061-1066.
14. Roll P, Rudolf G, Pereira S, et al. SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 2006; 15: 1195-1207.
15. Strug LJ, Clarke T, Chiang T, et al. Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to elongator protein complex 4 (ELP4). Eur J Hum Genet 2009; 17: 1171-1181.
16. Lal D, Reinthaler EM, Schubert J, et al. DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol 2014; 75: 814-816.
17. Scheffer IE, Heron SE, Regan BM, et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014; 75: 808-813.
18. Miki D, Ochi H, Hayes CN, et al. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet 2011; 43: 797-800.
19. Poduri A, Evrony GD, Cai X, et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012; 74: 41-48.
20. Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013; 45: 546-551.
21. Martin C, Meloche C, Rioux MF, et al. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population. Clin Genet 2013 Nov 1 [Epub ahead of print].
22. Krueger DA, Wilfong AA, Holland-Bouley K, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013; 74: 679-687.
23. Camfield CS, Camfield PR,. Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology 2014; 82: 1162-1166.